Cancer biotechnology is a multidisciplinary field that leverages advancements in biology, genetics, and technology to understand, diagnose, and treat various forms of cancer. This specialized branch of biotechnology focuses on developing innovative tools, techniques, and therapies to combat the complexities of cancer at the molecular level. Researchers in cancer biotechnology explore the genetic basis of cancer, enabling the identification of specific biomarkers and genetic mutations associated with different types of malignancies. This knowledge is instrumental in the development of targeted therapies and personalized medicine, tailoring treatment approaches to individual patients. Additionally, cancer biotechnology plays a pivotal role in diagnostic technologies, such as molecular imaging and liquid biopsy, offering more precise and less invasive methods for cancer detection. The ongoing advancements in cancer biotechnology hold promise for groundbreaking discoveries and transformative breakthroughs in the relentless pursuit of effective cancer prevention, diagnosis, and treatment strategies.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico